Products

Acarbose is a novel oral hypoglycemic agent. In the intestine of competitive inhibition of glycoside hydrolase, It reduces the polysaccharide and sucrose into glucose, slows down the corresponding uptake of sugar, so it can be with the postprandial blood glucose lowering effect. Generally used alone, or with other oral hypoglycemic agents or insulin therapy, with the food and beverage, treatment of insulin dependent and non dependent diabetes mellitus. Acarbose for carbohydrates in the small intestine is absorbed by slow decomposition, prolongs the retention time, the intestinal bacteria glycolysis and gas production increases, so it can cause abdominal distension, abdominal pain and diarrhea.

Glimepiride is the third generation sulfonylurea antidiabetic drug, having the functions of inhibiting synthesis of hepatic glucose, improving insulin-stimulated glucose transport in skeletal muscle and promoting insulin secretion. This product is suitable for type 2 diabetic patient who can’t control blood glucose by diet-treated only, exercise therapy and lose weight.